A Randomized Controlled Study of Vitrectomy Combined with Recombinant Tissue-Type Fibrinogen Activator Submacular Injection for the Treatment of Polypoid Choroidal Vasculopathy Complicated with Massive Submacular Hemorrhage.

Lingying Ye,Ronghan Wu,Jin LI,Zhixiang Hu
DOI: https://doi.org/10.23736/s0026-4806.22.08257-x
2022-01-01
Minerva Medica
Abstract:A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular haemorrhage
What problem does this paper attempt to address?